Zhao Yan profile photo

Zhao Yan

Global rank #1661 · Diversified
Estimated net worth
$2.46B
+$11.6M (0.47%) since the previous estimate
Updated Oct 16, 2026, 2:32 PM EDT

Profile details

Residence and biographical details are shown from cited sources. Time-sensitive facts are withheld when their supporting evidence is no longer current.

Residence
Beijing, China
Current source dated Mar 10, 2026 · Verified Sep 7, 2026

Zhao Yan built a controlling position in Bloomage Biotechnology and expanded it from a hyaluronic-acid supplier into a broader biotechnology and consumer-products group, while retaining ownership through companies she controls. [1][2][3]

Her wealth is tied to a controlling stake she built in biotechnology

Forbes identifies Zhao as chairman and chief executive of Bloomage Biotechnology and classifies her fortune as self-made, with the company's hyaluronic-acid business serving as the main listed asset behind her billionaire wealth. [1]

Hong Kong exchange filings show that Zhao controlled the majority shareholder vehicle behind Bloomage and held a majority economic interest in the earlier Hong Kong-listed company, directly linking her personal ownership to the operating business. [2]

A 2015 company filing described Zhao as having more than two decades of experience in biotechnology, investment and management and identified her as chairman as well as the controlling shareholder through a wholly owned investment vehicle. [3]

She expanded beyond ingredients into branded products and adjacent investments

Forbes says Zhao pushed Bloomage beyond supplying hyaluronic acid by establishing skincare brands and developing additional consumer applications, broadening the commercial model from ingredient manufacturing toward higher-value branded products. [1]

Her fortune therefore reflects retained control of a business she developed and expanded rather than inheritance of an established family company. The available evidence supports the standard self-created founder and owner anchor, without enough documented hardship to justify a higher disadvantage adjustment. [1][2][3]

Sources for background

Sources reviewed Oct 6, 2026.

  1. Zhao Yan · Forbes · Mar 10, 2026
  2. Bloomage BioTechnology Corporation Limited substantial shareholder filing · Hong Kong Exchanges and Clearing · Sep 12, 2014
  3. Bloomage BioTechnology Corporation Limited appointment announcement · Hong Kong Exchanges and Clearing · Jun 18, 2015

Comparable Diversified billionaires

Similar Diversified billionaires by estimated net worth.

Sources and calculations

Grizzly Bulls tracks this published net worth estimate over time and separately values identified public holdings when share counts and market prices are available. The total shown at the top currently uses the latest available Forbes estimate; holding values shown on this page do not replace it.

Background citations are listed with the background section so its numbered references remain easy to follow.